Showing 1 - 10 of 36
Persistent link: https://www.econbiz.de/10003968706
Persistent link: https://www.econbiz.de/10009667953
This review discusses the role of consumer-directed and physician-directed promotion in the pharmaceutical market, based on the classic conceptual framework of whether such promotion is "persuasive" and/or "informative". Implications for public health and welfare partly depend on whether, and to...
Persistent link: https://www.econbiz.de/10013086301
The purpose of this study is to estimate the effect of direct-to-consumer advertising (DTCA) of prescription drugs on prescription drug prices and sales. Major increases in broadcast DTCA began in August 1997 when the FDA eliminated the requirement that broadcast advertising present all of the...
Persistent link: https://www.econbiz.de/10013067715
Spending on prescription drugs (Rx) represents one of the fastest growing components of U.S. healthcare spending, and has coincided with an expansion of pharmaceutical promotional spending. Most (83%) of Rx promotion is directed at physicians in the form of visits by pharmaceutical...
Persistent link: https://www.econbiz.de/10013073325
Despite the significant cost of prescription (Rx) drug abuse and calls from policy makers for effective interventions, there is limited research on the effects of policies intended to limit such abuse. This study estimates the effects of prescription drug monitoring (PDMP) programs which is a...
Persistent link: https://www.econbiz.de/10012953511
We study the spillover effects of prescription drug monitoring programs (PDMPs) on crime, and in the process inform how policies that restrict access to Rx opioids per se within the healthcare system would impact broader non-health domains. In response to the substantial increase in opioid use...
Persistent link: https://www.econbiz.de/10012911712
Persistent link: https://www.econbiz.de/10010210731
We study the spillover effects of prescription drug monitoring programs (PDMPs) on crime, and in the process inform how policies that restrict access to Rx opioids per se within the healthcare system would impact broader non-health domains. In response to the substantial increase in opioid use...
Persistent link: https://www.econbiz.de/10012480628
Expenditures on prescription drugs are one of the fastest growing components of national health care spending, rising by almost three-fold between 1995 and 2007. Coinciding with this growth in prescription drug expenditures has been a rapid rise in direct-to-consumer advertising (DTCA), made...
Persistent link: https://www.econbiz.de/10012462683